Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.6350
+0.0650 (4.14%)
NASDAQ· Last Trade: May 20th, 11:40 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors